Acquisitions

HEADLINE_ROUNDUP

Source: LSEG data | Sriparna Roy

Headline Roundup

Kimberly-Clark to Acquire Kenvue in a $48.7 Billion Deal

From the Center

Kimberly-Clark bets $40 billion for Kenvue despite Tylenol controversy

Reuters

From the Left

Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant

CNBC

From the Right

Kimberly-Clark to buy Tylenol maker Kenvue for nearly $50 billion

Just The News

Balanced News about Acquisitions on AllSides

News from the Left

News from the Center

News from the Right

Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant

CNBC

Kimberly-Clark bets $40 billion for Kenvue despite Tylenol controversy

Reuters

France's Sanofi to buy U.S. drugs project INBRX-101 for about $2.2 billion

Reuters

Merck to buy Prometheus Biosciences for about $11 billion

Reuters

Kimberly-Clark to buy Tylenol maker Kenvue for nearly $50 billion

Just The News

Balanced News about Acquisitions from Across the Web Powered by Google. Enhanced by AllSides.

AllSides Balanced Search™ gives you recent news from outlets on all sides of the political spectrum so you can get the full picture.